
|Videos|March 12, 2022
Augmenting corneal thickness with FDA-approved hypotonic riboflavin
Author(s)Alex Delaney-Gesing, Senior Editor
Daniel Fuller, OD, FAAO Dipl., FSLS, discusses augmenting corneal thickness in thin keratoconus corneas during corneal cross-linking via FDA-approved hypotonic riboflavin during SECO 2022.
Advertisement
Daniel Fuller, OD, FAAO Dipl., FSLS, discusses his SECO 2022 presentation "Augmenting corneal thickness in thin keratoconus corneas during corneal cross-linking via FDA-approved hypotonic riboflavin," with Optometry Times®' Alex Delaney-Gesing.
Newsletter
Want more insights like this? Subscribe to Optometry Times and get clinical pearls and practice tips delivered straight to your inbox.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Optometry Times - Clinical News & Expert Optometrist Insights
1
Early SPECTRUM results outline week 8 real-world outcomes with aflibercept 8 mg
2
Higher head elevation during sleep may be associated with higher IOP, study suggests
3
Contact Lens Institute rings in 2026 Visionaries
4
Alcon's PRECISION7 sphere, toric contact lenses now available in Canada
5




























